Free Trial

OptiBiotix Health (OPTI) Competitors

OptiBiotix Health logo
GBX 17.40 -0.10 (-0.57%)
As of 02/21/2025 11:39 AM Eastern

OPTI vs. MRK, CYAN, PHE, REVB, OKYO, ALT, IGAS, CRDL, IDP, and IRON

Should you be buying OptiBiotix Health stock or one of its competitors? The main competitors of OptiBiotix Health include Marks Electrical Group (MRK), CyanConnode (CYAN), PowerHouse Energy Group (PHE), Revolution Beauty Group (REVB), OKYO Pharma (OKYO), Altitude Group (ALT), IGas Energy (IGAS), Cordel Group (CRDL), InnovaDerma (IDP), and Ironveld (IRON). These companies are all part of the "pharmaceutical products" industry.

OptiBiotix Health vs.

Marks Electrical Group (LON:MRK) and OptiBiotix Health (LON:OPTI) are both small-cap consumer cyclical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, community ranking, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

11.2% of Marks Electrical Group shares are held by institutional investors. Comparatively, 4.9% of OptiBiotix Health shares are held by institutional investors. 79.3% of Marks Electrical Group shares are held by company insiders. Comparatively, 12.0% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Marks Electrical Group has a net margin of 0.37% compared to OptiBiotix Health's net margin of -524.43%. Marks Electrical Group's return on equity of 3.05% beat OptiBiotix Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Marks Electrical Group0.37% 3.05% 0.91%
OptiBiotix Health -524.43%-36.76%-13.93%

In the previous week, Marks Electrical Group's average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
Marks Electrical Group Neutral
OptiBiotix Health Neutral

Marks Electrical Group has higher revenue and earnings than OptiBiotix Health. OptiBiotix Health is trading at a lower price-to-earnings ratio than Marks Electrical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marks Electrical Group£114.24M0.50£426.93K£0.41133.97
OptiBiotix Health£590.01K28.88-£3.09M-£3.16-5.51

OptiBiotix Health received 129 more outperform votes than Marks Electrical Group when rated by MarketBeat users. However, 76.19% of users gave Marks Electrical Group an outperform vote while only 59.18% of users gave OptiBiotix Health an outperform vote.

CompanyUnderperformOutperform
Marks Electrical GroupOutperform Votes
16
76.19%
Underperform Votes
5
23.81%
OptiBiotix HealthOutperform Votes
145
59.18%
Underperform Votes
100
40.82%

Marks Electrical Group currently has a consensus price target of GBX 100, suggesting a potential upside of 83.49%. Given Marks Electrical Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe Marks Electrical Group is more favorable than OptiBiotix Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marks Electrical Group
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
OptiBiotix Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Marks Electrical Group has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, OptiBiotix Health has a beta of 1.71, indicating that its stock price is 71% more volatile than the S&P 500.

Summary

Marks Electrical Group beats OptiBiotix Health on 13 of the 16 factors compared between the two stocks.

Get OptiBiotix Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OPTI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPTI vs. The Competition

MetricOptiBiotix HealthBiotechnology IndustryMedical SectorLON Exchange
Market Cap£17.04M£117.96M£5.81B£2.62B
Dividend YieldN/A3.69%4.77%4.99%
P/E Ratio-5.513.2021.50162.98
Price / Sales28.884,826.69453.19311,100.01
Price / Cash8.6813.0143.9627.91
Price / Book2.2347.077.655.13
Net Income-£3.09M-£87.82M£3.18B£5.71B
7 Day Performance16.00%0.35%-1.95%-1.05%
1 Month Performance-0.57%3.62%-0.23%-0.81%
1 Year Performance-20.91%99.12%16.69%39.53%

OptiBiotix Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPTI
OptiBiotix Health
N/AGBX 17.40
-0.6%
N/A-22.3%£17.04M£590,009.23-5.511Gap Up
MRK
Marks Electrical Group
2.149 of 5 stars
GBX 55
+0.9%
GBX 100
+81.8%
-25.9%£57.72M£114.24M135.20200
CYAN
CyanConnode
N/AGBX 13.82
-1.3%
N/A+8.5%£48.29M£23.07M-10.29100Gap Down
PHE
PowerHouse Energy Group
N/AGBX 0.95
flat
N/A+188.6%£43.61M£623,951.84-21.444
REVB
Revolution Beauty Group
N/AGBX 11.88
-0.2%
N/A-56.1%£38.00M£173.87M-69.2410Positive News
Gap Down
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
ALT
Altitude Group
N/AGBX 28
+5.7%
N/A-8.9%£20.37M£23.50M29.9650Gap Down
IGAS
IGas Energy
N/AN/AN/AN/A£18.97M£59.17M-148.90100Gap Up
CRDL
Cordel Group
N/AGBX 7.31
-2.5%
N/A+76.1%£15.86M£4.83M-11.2335
IDP
InnovaDerma
N/AN/AN/AN/A£8.14M£9.82M-3.878,720
IRON
Ironveld
N/AN/AN/AN/A£5.29MN/A-2.6230

Related Companies and Tools


This page (LON:OPTI) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners